EndoSound, Inc. — SEC Form D Filing

EndoSound, Inc. filed an SEC Form D on June 17, 2026, reporting $250K raised in Medical Devices.

Form D filing details

Filing
SEC Form D
Filing date
June 17, 2026
Amount reported
$250K
Industry
Medical Devices
Website
https://endosound.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Traditional Endoscopic Ultrasound (EUS) systems are expensive and limit access to only larger healthcare facilities, making it difficult for smaller clinics or ambulatory surgery centers to offer this diagnostic procedure.

Solution

EndoSound offers a system that converts standard upper GI endoscopes into a full EUS system at a fraction of the cost, expanding access to EUS procedures in more settings.

Why now

There is a growing demand for advanced diagnostic procedures like EUS in more accessible settings, such as ambulatory surgery centers, driven by cost pressures and patient preferences for outpatient care.

Verdict

Investors backed this because it offered a clear cost-reduction story for existing procedures, not because it introduced truly novel diagnostic capabilities. They were implicitly betting on the immediate economic incentive for smaller facilities to adopt a proven diagnostic without significant capital outlay. This limited upside, however, as the solution primarily optimizes an established workflow rather than opening new markets or creating proprietary diagnostic intelligence.

Source: SEC EDGAR Form D filing